BMEA Latest Headlines

Biomea Fusion GAAP EPS of -$0.17 beats by $0.07

at seekingalpha.com (Mon, 11-May 5:25 PM)

Biomea Fusion’s Phase II Diabetes Trials Target Critical Unmet Needs: What the Latest Milestone Means for Patients and Investors

Market Chameleon (Tue, 31-Mar 11:07 AM)

Biomea Fusion Projects Multiple Clinical Data Readouts in 2026 as R&D Spending Drops 47%

Market Chameleon (Wed, 25-Mar 11:58 AM)